SCHEMBL1994738

SCHEMBL1994738

CC(C)(O)CN1CCC(n2nc(C3=C(c4c[nH]c5ccsc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 10/20 0.40
PRKCE Q02156 10/20 0.40
CAMK2D Q13557 9/20 0.40
PRKCB P05771 9/20 0.40
PRKCH P24723 9/20 0.40
PRKCD Q05655 9/20 0.40
PRKCG P05129 8/20 0.40
CAMK2B Q13554 6/20 0.40
CAMK2G Q13555 6/20 0.40
CAMK2A Q9UQM7 6/20 0.40
PRKCZ Q05513 5/20 0.40
SRC P12931 3/20 0.40
HTR4 Q13639 2/20 0.37
PRKCQ Q04759 4/20 0.36
PIM1 P11309 4/20 0.36
GSK3B P49841 3/20 0.36
CDK2 P24941 3/20 0.36
PDGFRB P09619 2/20 0.36
RPS6KB1 P23443 2/20 0.36
AXL P30530 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998512 0.91 PRKCA (0.39) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1995704 0.91 CAMK2D (0.41) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1989963 0.88 PRKCB (0.38) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1990865 0.87 CAMK2D (0.45) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1992944 0.86 PRKACA (0.44) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1994230 0.86 PRKCB (0.43) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1997240 0.86 CAMK2D (0.41) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1992525 0.85 CAMK2D (0.57) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1998834 0.81 PRKCH (0.44) PRKCAPRKCECAMK2DPRKCBPRKCH
SCHEMBL1996632 0.80 PRKCH (0.43) PRKCAPRKCECAMK2DPRKCBPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCA 3438/4885PRKCE 3431/4885CAMK2D 2963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.